लोड हो रहा है...
Identification of favorable subgroups for alternative anti-androgen therapy in castration-resistant prostate cancer
Although alternative anti-androgen therapy (switching to secondary anti-androgens) is no longer recommended in the clinical guidelines of prostate cancer in light of the new hormonal and cytotoxic agents available, this therapy has proven beneficial for some patients with castration-resistant prosta...
में बचाया:
| में प्रकाशित: | Mol Clin Oncol |
|---|---|
| मुख्य लेखकों: | , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
D.A. Spandidos
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6787950/ https://ncbi.nlm.nih.gov/pubmed/31620284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1915 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|